A practical guide for buprenorphine initiation in the primary care setting.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37657832.
- Also identified by DOI 10.3949/ccjm.90a.23022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Buprenorphine is a safe and effective treatment for opioid use disorder but remains underutilized because a major challenge of conventional buprenorphine initiation (termed <i>induction</i>) is that the patient must already be in opioid withdrawal. Previous legal barriers and clinician lack of familiarity with the unique pharmacology of buprenorphine have also limited its use. In this review, we outline changes regarding buprenorphine prescribing laws and physician perceptions of buprenorphine. We also review buprenorphine pharmacology and novel low-dose buprenorphine induction procedures that can be adopted in primary care settings to improve treatment acceptability, retention, and outcomes.
Medical subject headings
- Buprenorphine
- Opioid-Related Disorders
- Physicians
- Substance Withdrawal Syndrome